NCT07713797Recruiting
Biomarkers for Endometriosis
A Prospective, Observational and Multicentric Study to Evaluate the Performance and Clinical Utility of EndoID ELISA Kit to Determine Circulating Synuclein Gamma (SNCG) and B-cell Lymphoma-6 (BCL6) Levels as Potential Biomarkers for Endometriosis"
Source: ClinicalTrials.gov · Last updated 3 Aug 2026
Brief summary (registry, in English)
Endometriosis is a condition in which tissue similar to the lining of the uterus grows outside the uterus, often causing pain and infertility. Currently, endometriosis can only be definitively diagnosed through invasive procedures like laparoscopy and biopsy. The purpose of this study is to investigate whether the proteins Synuclein Gamma (SNCG) and B-Cell Lymphoma 6 (BCL6), measurable in blood and menstrual fluid, can serve as non-invasive biomarkers to diagnose or monitor endometriosis.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 100 (estimated)
- First submitted
- 16 Jun 2026
- Start date
- 16 Jan 2026
- Primary completion date
- 1 Jan 2027
- Lead sponsor
- Trio Fertility
- Diseases
- Endometriosis
- NCT number
- NCT07713797
What you commit to
- Study type: Observational
- Planned participants: 100
- From 16 Jan 2026 to the primary completion date, 1 Jan 2027
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Current or prior history of uterine, ovarian, colon, pancreatic, breast or any other type of cancer.
- Any prior history of chronic illness.
- Prior history of any disease including cancer or chronic illness.
Other
- Women \<18Y and \>45Y.
- Women with endometriosis during stimulation with gonadotropins.
- Pregnant women.
- Women \<18Y and \>45Y
- Pregnant women.
Who the study is looking for
- Women of reproductive age group (18Y-45Y).
- Women with active endometriosis diagnosed by ultrasound/MRI/laparoscopy.
- Women of reproductive age group (18Y-45Y).
- Women without endometriosis and any other gynaecological problem.
Age in the registry: 18 years to 45 years · Sex: Female · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Trio Fertility Coordinator of this site? Confirm its status | Toronto | Canada | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.